Skip to Main Content

Author Details

Peter K Rogan
CytoGnomix Inc.
1981
117
34
PMIDPaper TitleJournal TitlePublished Year
37721084Radiation exposure determination in a secure, cloud-based online environment.Radiat Prot Dosimetry2023
34606416Gene expression for biodosimetry and effect prediction purposes: promises, pitfalls and future directions - key session ConRad 2021.Int J Radiat Biol2022
34699300Improved radiation expression profiling in blood by sequential application of sensitive and specific gene signatures.Int J Radiat Biol2022
34670606Differentially accessible, single copy sequences form contiguous domains along metaphase chromosomes that are conserved among multiple tissues.Mol Cytogenet2021
32330192Meeting radiation dosimetry capacity requirements of population-scale exposures by geostatistical sampling.PLoS One2020
34766125Pathway-extended gene expression signatures integrate novel biomarkers that improve predictions of patient responses to kinase inhibitors.MedComm (2020)2020
32910711Estimating partial-body ionizing radiation exposure by automated cytogenetic biodosimetry.Int J Radiat Biol2020
32644817Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical Practices.JCO Clin Cancer Inform2020
32211018Expression Changes Confirm Genomic Variants Predicted to Result in Allele-Specific, Alternative mRNA Splicing.Front Genet2020
30624749RADIATION DOSE ESTIMATION BY COMPLETELY AUTOMATED INTERPRETATION OF THE DICENTRIC CHROMOSOME ASSAY.Radiat Prot Dosimetry2019
31451418Multigene signatures of responses to chemotherapy derived by biochemically-inspired machine learning.Mol Genet Metab2019
30652029Predicting responses to platin chemotherapy agents with biochemically-inspired machine learning.Signal Transduct Target Ther2019
29236234Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.Breast Cancer Res Treat2018
30204945BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.Hum Mutat2018
30464680Survival outcome differences based on treatments used and knowledge of the primary tumour site for patients with cancer of unknown and known primary in Ontario.Curr Oncol2018
28324922The Clinical Significance of Occult Gastrointestinal Primary Tumours in Metastatic Cancer: A Population Retrospective Cohort Study.Cancer Res Treat2018
29623630The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study.Pharmacoecon Open2018
27019982Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary.Pharmacogenomics J2017
28097472Proceedings of the third international molecular pathological epidemiology (MPE) meeting.Cancer Causes Control2017
29026522Accurate cytogenetic biodosimetry through automated dicentric chromosome curation and metaphase cell selection.F1000Res2017
29089807The clinical significance of occult gynecologic primary tumours in metastatic cancer.Curr Oncol2017
28664506Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.Breast Cancer Res Treat2017
28892030Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation.J Vis Exp2017
27899659Discovery and validation of information theory-based transcription factor and cofactor binding site motifs.Nucleic Acids Res2017
26898890Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations.Hum Mutat2016
26372358Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning.Mol Oncol2016
27412514Radiation Dose Estimation by Automated Cytogenetic Biodosimetry.Radiat Prot Dosimetry2016
27067391A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.BMC Med Genomics2016
26929213Automated discrimination of dicentric and monocentric chromosomes by machine learning-based image processing.Microsc Res Tech2016
25825957Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.Acta Oncol2015
26273322Reversing chromatin accessibility differences that distinguish homologous mitotic metaphase chromosomes.Mol Cytogenet2015
26130695FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.Hum Mol Genet2015
24757176Automating dicentric chromosome detection from cytogenetic biodosimetry data.Radiat Prot Dosimetry2014
25717368Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis.F1000Res2014
25520753Localized, non-random differences in chromatin accessibility between homologous metaphase chromosomes.Mol Cytogenet2014
25394353Splicing mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancer.Sci Rep2014
23348723Prediction of mutant mRNA splice isoforms by information theory-based exon definition.Hum Mutat2013
23955774Best practices for evaluating mutation prediction methods.Hum Mutat2013
23434602Intensity integrated Laplacian-based thickness measurement for detecting human metaphase chromosome centromere location.IEEE Trans Biomed Eng2013
23499923Interpretation, stratification and evidence for sequence variants affecting mRNA splicing in complete human genome sequences.Genomics Proteomics Bioinformatics2013
23548580Relating centromeric topography in fixed human chromosomes to α-satellite DNA and CENP-B distribution.Cytogenet Genome Res2013
23376933Expanding probe repertoire and improving reproducibility in human genomic hybridization.Nucleic Acids Res2013
22342187Structural and genic characterization of stable genomic regions in breast cancer: relevance to chemotherapy.Mol Oncol2012
21523855Comprehensive prediction of mRNA splicing effects of BRCA1 and BRCA2 variants.Hum Mutat2011
21824424Context-based FISH localization of genomic rearrangements within chromosome 15q11.2q13 duplicons.Mol Cytogenet2011
20358580Deeper understanding of unclassified intronic variants and ESEs.Hum Mutat2010
20513139Usher syndrome splicing variants evaluated in nasal epithelial cells.Hum Mutat2010
16287154Splice-site contribution in alternative splicing of PLP1 and DM20: molecular studies in oligodendrocytes.Hum Mutat2006
16503993BIPAD: a web server for modeling bipartite sequence elements.BMC Bioinformatics2006
16460913Dendrimer FISH detection of single-copy intervals in acute promyelocytic leukemia.Mol Cell Probes2006
  • 1 - 50 of 117

Recommended Authors

Children's Hospital of Philadelphia
Career Start Year 2004
Number of shared co-authors 2
Broad Institute of MIT and Harvard
Career Start Year 2001
Number of shared co-authors 3
Genentech Inc.
Career Start Year 1999
Number of shared co-authors 1
McGill University and Genome Quebec Innovation Centre
Career Start Year 1998
Number of shared co-authors 1
Centene Center for Health Transformation, Centene Corporation
Career Start Year 1998
Number of shared co-authors 10
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 0
University of Washington
Career Start Year 1997
Number of shared co-authors 0
Harvard T.H. Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 3
University of Washington
Career Start Year 1996
Number of shared co-authors 6
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 4
National Cancer Institute, National Institutes of Health
Career Start Year 1993
Number of shared co-authors 1
Center for Inherited Disease Research, Johns Hopkins School of Medicine
Career Start Year 1993
Number of shared co-authors 17
Baylor College of Medicine
Career Start Year 1992
Number of shared co-authors 5
Ontario Institute for Cancer Research
Career Start Year 1991
Number of shared co-authors 5
Baylor College of Medicine
Career Start Year 1991
Number of shared co-authors 9
University of Washington
Career Start Year 1988
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 1988
Number of shared co-authors 6
Baylor College of Medicine
Career Start Year 1987
Number of shared co-authors 2
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 1
Baylor College of Medicine
Career Start Year 1987
Number of shared co-authors 8
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 1987
Number of shared co-authors 1
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Career Start Year 1986
Number of shared co-authors 4
Ontario Institute for Cancer Research
Career Start Year 1986
Number of shared co-authors 3
McGill University
Career Start Year 1986
Number of shared co-authors 1
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 2
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 2
The Ohio State University
Career Start Year 1983
Number of shared co-authors 7
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 12
HudsonAlpha Institute for Biotechnology
Career Start Year 1980
Number of shared co-authors 2
University of California, USA Institute for Genomic Medicine
Career Start Year 1967
Number of shared co-authors 2

Collaborators

Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 6
Co-authored papers 4
Johns Hopkins University School of Medicine
Co-authored papers 2
Ospedale Circolo e Fondazione Macchi
Co-authored papers 2
Co-authored papers 2
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 2
University of Pittsburgh
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Instituto de Salud Carlos III
Co-authored papers 1
QIMR Berghofer Medical Research Institute
Co-authored papers 1
QIMR Berghofer Medical Research Institute
Co-authored papers 1
Washington University
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
KTH Royal Institute of Technology
Co-authored papers 1
Leiden University Medical Center
Co-authored papers 1
Georgetown University Medical Center
Co-authored papers 1
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 1
Washington University
Co-authored papers 1
University of Utah
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 1
Lombardi Comprehensive Cancer Center, Georgetown University
Co-authored papers 1
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Weizmann Institute of Science
Co-authored papers 1
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 1
Health Sciences University of Hokkaido
Co-authored papers 1
Frederick National Laboratory for Cancer Research
Co-authored papers 1
Harvard T. H. Chan School of Public Health
Co-authored papers 1
University of Siena
Co-authored papers 1